LLY
Eli Lilly & Co.
Company · XNYS · US · USD
Market price
$1,220.54
+$253.55 (+26.22%) · 3 months
| Date and time | Price |
|---|---|
| May 11, 2026 | $966.99 |
| May 12, 2026 | $971.12 |
| May 13, 2026 | $990.27 |
| May 14, 2026 | $1,019.01 |
| May 15, 2026 | $1,004.80 |
| May 18, 2026 | $988.09 |
| May 19, 2026 | $992.38 |
| May 20, 2026 | $1,024.71 |
| May 21, 2026 | $1,026.50 |
| May 22, 2026 | $1,049.00 |
| May 26, 2026 | $1,064.74 |
| May 27, 2026 | $1,083.91 |
| May 28, 2026 | $1,127.05 |
| May 29, 2026 | $1,105.31 |
| Jun 1, 2026 | $1,082.20 |
| Jun 2, 2026 | $1,064.70 |
| Jun 3, 2026 | $1,082.30 |
| Jun 4, 2026 | $1,125.51 |
| Jun 5, 2026 | $1,131.42 |
| Jun 8, 2026 | $1,149.15 |
| Jun 9, 2026 | $1,144.68 |
| Jun 10, 2026 | $1,136.37 |
| Jun 11, 2026 | $1,160.95 |
| Jun 12, 2026 | $1,133.00 |
| Jun 15, 2026 | $1,129.35 |
| Jun 16, 2026 | $1,122.50 |
| Jun 17, 2026 | $1,112.00 |
| Jun 18, 2026 | $1,098.57 |
| Jun 22, 2026 | $1,102.08 |
| Jun 23, 2026 | $1,107.08 |
| Jun 24, 2026 | $1,117.26 |
| Jun 25, 2026 | $1,127.69 |
| Jun 26, 2026 | $1,208.12 |
| Jun 29, 2026 | $1,229.93 |
| Jun 30, 2026 | $1,199.43 |
| Jul 1, 2026 | $1,191.74 |
| Jul 2, 2026 | $1,213.91 |
| Jul 6, 2026 | $1,200.06 |
| Jul 7, 2026 | $1,235.56 |
| Jul 8, 2026 | $1,215.83 |
| Jul 9, 2026 | $1,216.95 |
| Jul 10, 2026 | $1,188.58 |
| Jul 13, 2026 | $1,181.87 |
| Jul 14, 2026 | $1,152.54 |
| Jul 15, 2026 | $1,156.63 |
| Jul 16, 2026 | $1,169.17 |
| Jul 17, 2026 | $1,179.11 |
| Jul 20, 2026 | $1,146.90 |
| Jul 21, 2026 | $1,175.41 |
| Jul 22, 2026 | $1,163.01 |
| Jul 23, 2026 | $1,185.87 |
| Jul 24, 2026 | $1,196.03 |
| Jul 27, 2026 | $1,197.53 |
| Jul 28, 2026 | $1,220.66 |
| Jul 29, 2026 | $1,210.02 |
| Jul 30, 2026 | $1,154.97 |
| Jul 31, 2026 | $1,148.84 |
| Aug 3, 2026 | $1,121.36 |
| Aug 4, 2026 | $1,115.68 |
| Aug 5, 2026 | $1,169.86 |
| Aug 6, 2026 | $1,191.94 |
| Aug 7, 2026 | $1,185.71 |
| Aug 10, 2026 | $1,220.54 |
- Period change
- +26.22%
- Period low
- $966.99
- Period high
- $1,235.56
- Observations
- 63
- Updated
- Aug 10, 2026, 6:25 PM
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $1,024,468,196,869.04
- Employees
- 50K